Mark Ragosa - CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
KNSA on Nasdaq
All Insider Reports
All Insider Reports

Mark Ragosa - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Share 23K $491K $21.38 Dec 9, 2024 Direct
Class A Common Share 19.3K $344K $17.88 Apr 26, 2024 Direct
Performance Share Unit 5.09K $91.1K $17.90 Apr 4, 2024 Direct Class A Common Share
Share Option 21.6K Dec 9, 2024 Direct Class A Ordinary Share
Restricted Share Unit 1.86K Sep 2, 2024 Direct Class A Ordinary Share
Restricted Share Unit 990 Apr 26, 2024 Direct Class A Common Share

Transactions reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.